STAGING OF TESTIS CANCER: Combining Serum Markers, Histologic Parameters, and Radiographic Imaging
- 1 August 1998
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 25 (3) , 397-403
- https://doi.org/10.1016/s0094-0143(05)70030-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Improved Accuracy of Computerized Tomography Based Clinical Staging in Low Stage Nonseminomatous Germ Cell Cancer Using Size Criteria of Retroperitoneal Lymph NodesJournal of Urology, 1995
- Testicular cancerCurrent Opinion in Oncology, 1994
- Cytogenetic and molecular analysis of human male germ cell tumors: Chromosome 12 abnormalities and gene amplificationGenes, Chromosomes and Cancer, 1990
- Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reactionGenes, Chromosomes and Cancer, 1990
- Identifying patients with low risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillanceUrology, 1989
- Value of Computed Tomography in the Staging of Testicular TumorsUrologia Internationalis, 1988
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- Accuracy of radiological staging procedures in non-seminomatous testis cancer compared with findings from surgical exploration and histopathological studies of extirpated tissueThe British Journal of Radiology, 1986
- Comparison of NMR and CT Imaging in the Evaluation of Metastatic Retroperitoneal Lymphadenopathy from Testicular CarcinomaJournal of Computer Assisted Tomography, 1984
- Evaluation of Computed Tomography in the Management of Testicular TeratomaBritish Journal of Urology, 1981